Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials?-Reference-Cited by-同舟云学术

Imatinib as the first-line treatment of patients with chronic myeloid leukemia diagnosed in the chronic phase: Can we compare real life data to the results from clinical trials?

Published:2011-02-15 Issue:3 Volume:86 Page:318-321
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Zackova Daniela,Klamova Hana,Dusek Ladislav,Muzik Jan,Polakova Katerina Machova,Moravcova Jana,Jurcek Tomas,Dvorakova Dana,Racil Zdenek,Pospisil Zdenek,Oltova Alexandra,Michalova Kyra,Brezinova Jana,Razga Filip,Doubek Michael,Cetkovsky Petr,Trneny Marek,Mayer Jiri

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ajh.21942/fullpdf

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RENO Study: Clinical characteristics, treatment patterns and survival results in patients with metastatic renal cell carcinoma in Northern Spain;Seminars in Oncology;2024-06

2. Chronic myeloid leukaemia in the South African public health setting: Are we reaching the European LeukemiaNet targets for frontline therapy?;South African Journal of Oncology;2020-12-09

3. Dasatinib treatment long-term results among imatinib-resistant/intolerant patients with chronic phase chronic myeloid leukemia are favorable in daily clinical practice;Leukemia & Lymphoma;2020-10-06

4. Real life patterns of care and progression free survival in metastatic renal cell carcinoma patients: retrospective analysis of cross-sectional data;BMC Cancer;2018-02-21

5. Current approach for chronic myeloid leukemia treatment with tyrosin kinase inhibitors;Onkologie;2016-06-01